Erudio Healtherudio.com
Clinical trial · no report yet · Phase not applicable
PRIME trial: what clinicians have said so far
Prostate Radiotherapy Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial)
- NCT03561961 ↗
- Active, not recruiting
- Tata Memorial Centre
- Focused size, estimated: 1–150 verified statements once built
We haven't built an HCP commentary report on PRIME yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on PRIME so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 3 posts on X, typically up to 13 once built |
The trial
ClinicalTrials.gov- Official title
- Randomised Controlled Trial of Prostate Radiotherapy In High Risk and Node Positive Disease Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial)
- Phase
- Phase not applicable
- Status
- Active, not recruiting
- Conditions
- Prostate Adenocarcinoma
- Interventions
- Moderate Hypo-fractionation; Extreme Hypo-fractionation
- Arms
- Moderate Hypo-fractionation · Active comparator
- Extreme Hypo-fractionation · Experimental
- Enrollment
- 526
- Primary outcomes
- Biochemical Failure free Survival (BFFS)
- Sponsor
- Tata Memorial Centre with Tata Medical Center
- Start
- May 24, 2018
- Primary completion
- Sep 27, 2024
- Results posted
- No
- Registry record
- NCT03561961 · updated Feb 13, 2025
Publications
linked from the registry- Murthy V, Mallick I, Gavarraju A, Sinha S, Krishnatry R, Telkhade T, Moses A, Kannan S, Prakash G, Pal M, Menon S, Popat P, Rangarajan V, Agarwal A, Kulkarni S, Bakshi G. Study protocol of a randomised controlled trial of prostate radiotherapy in high-risk and node-positive disease comparing moderate and extreme hypofractionation (PRIME TRIAL). BMJ Open. 2020 Feb 28;10(2):e034623. doi: 10.1136/bmjopen-2019-034623. PubMed 32114475
- Murthy V, Gulati S, Ghosh S, Sable S, Phurailatpam R, Patil D, Mhatre R, Chougle N, Solanki M, Singh M, Verma P, Singh P, Maitre P. Empty-RT: A Phase 2 Trial of Prostate Stereotactic Body Radiation Therapy With an Empty Bladder Approach. Int J Radiat Oncol Biol Phys. 2026 Jul 31:S0360-3016(26)04064-2. doi: 10.1016/j.ijrobp.2026.07.018. Online ahead of print. PubMed 42537851